Richard Tolley, Vice President Integrated Market Access Solutions at Parexel discusses a recent roundtable discussion about the role of early payer insights in real-world data studies.
1:17Ste Nadin, Vice President Enterprise Architecture, discuss the value of architecture within the industry and Parexel Informatics, and the type of person who would fit well in the team.
0:58Simon Sering, Director for Software Engineering talks about his role within Parexel Informatics
1:02Ste Nadin shares why he likes the work he does and why he likes working for Parexel Informatics
1:28Simon Shering, Director of Software Engineering, talks about what makes it a great time to be joining Parexel Informatics.
1:23Ste Nadin, Vice President of Enterprise Architecture, discusses our sector and the important role Architects play within Parexel.
0:59Simon Shering, Director of Software Engineering, talks about why he likes working for Parexel and how he achieves a work life balance.
5:04Parexel experts discuss the current state of treatment for Duchenne Muscular Dystrophy as a supporter of the Jett Foundation’s virtual World Duchenne Awareness Day celebration, taking place Sept. 7-11
2:56Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
2:53Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
2:15Parexel’s Leanne Larson, Corporate VP and WW Head, Real-world Evidence speaks with Deborah Collyar, cancer survivor and President of Advocates in Research about the importance of Real-world Evidence (
0:45At Parexel, we are Project Leaders, not managers. During these unprecedented times, we have forged ahead—innovating and accelerating our impact. During this presentation, we'll share with you the wa
3:04Sy Pretorius, EVP and Chief Medical & Scientific Officer, Parexel and Gadi Saarony, CEO, Advarra discuss how industry-leading innovations help to reduce the time and cost of development, minimize the
1:21Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-world Evidence and FDA/Regulatory expertise to develop and execute a Synthet
1:21Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-world Evidence and FDA/Regulatory expertise to develop and execute a Synthet
1:21Parexel experts discuss a recent project involving a Rare Disease Oncology therapeutic, in which our experts leveraged Real-World Evidence and FDA/Regulatory expertise to develop and execute a Synthet
2:35Parexel's #KeepingPatientsFirst is a real world evidence research platform powered by Microsoft Azure. It provides patients and physicians collective knowledge surrounding COVID-19, and the promising
1:27Parexel proudly recognizes the significant contributions of our teams on the front lines for keeping patients first during COVID-19.
1:55Parexel’s Global Head of Parexel FSP, Chris Baker and Neil Berger, VP, Enterprise Account Leader discuss how our award-winning client service, innovation, therapeutic expertise and patient-centric sol
2:56Parexel’s Anita Nelsen, SVP, Translational Medicine and Michelle Hoiseth, Chief Data Officer, Corporate VP speak with Ashley Druckenmiller about caring with her two sons with hemophilia and the benefi
2:41Parexel’s Andreas Reiff, VP, Global TA Head, Inflammation/Immunology talks with Julie Stover, Senior Director, Solution Consulting, also from Parexel, about her journey being diagnosed with Ankylosing
